NSEGeneral Updates2d ago · 29 Oct 2026, 03:10 pm

General Updates

Laurus Labs Limited · LAURUSLABS

✦ AI SummaryMgmt Change

Laurus Labs Limited has informed the Exchange about the appointment of Mr. Kundan Kumar Jha as Joint Company Secretary of the Company, effective from November 1, 2026.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Laurus Labs Limited has informed the Exchange about appointment of Mr. Kundan Kumar Jha as Joint Company Secretary of the Company w.e.f. November 1, 2026

Attachments (1)

📄

LAURUSLABS_29102026151022_JointCS29102026.pdf

pdf

Download →
View document text
October 29, 2026 To To The Corporate Relations Department The Listing Department BSE Limited National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai – 400 001 Mumbai – 400 051 Code: 540222 Code: LAURUSLABS Dear Sir / Madam, Sub: Approval for the appointment of Mr. Kundan Kumar Jha as Joint Company Secretary Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we would like to inform that the Board of Directors of the Company at their meeting held on October 29, 2026, has inter alia based on the recommendation of the Nomination and Remuneration Committee and in line with the Company’s succession planning process, approved the appointment of Mr. Kundan Kumar Jha (Associate Member of the Institute of Company Secretaries of India holding Membership No. A17612), as Joint Company Secretary, being a Key Managerial Personnel of the Company, with effect from November 1, 2026. The relevant details as required under the SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, including a brief profile of Mr. Kundan Kumar Jha is annexed herewith as Annexure. The Board Meeting commenced at 02.00 p.m. (IST) and concluded at 02.47 p.m. (IST). This is for your information and records. Thanking you. Yours sincerely, For Laurus Labs Limited V V Ravi Kumar Executive Director and CFO DIN: 01424180 Encl: A/a Annexure Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Pursuant to SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026) Approval for the appointment of Mr. Kundan Kumar Jha, as Joint Company Secretary a Reason for change viz. appointment, Appointment of Mr. Kundan Kumar Jha (Associate Member re-appointment, resignation, of the Institute of Company Secretaries of India holding removal, death or otherwise Membership No. A17612), as Joint Company Secretary, being a Key Managerial Personnel of the Company, in line with Company’s succession planning process. b Date of appointment/ re- Appointment shall be effective from November 1, 2026 appointment/ cessation (as applicable) & term of appointment/ re-appointment c Brief profile (in case of Mr. Kundan is a qualified Company Secretary and a member appointment) of the Institute of Company Secretaries of India (ICSI). He brings over 23 years of extensive experience in corporate governance, board processes, regulatory compliance, corporate law, listing regulations, and legal affairs. Before joining Laurus, he was associated with Cohance Lifesciences Limited as Company Secretary and Head of Legal. Earlier in his career, he held key positions at Dr. Reddy’s Laboratories Limited, Rupa & Company Limited, Balrampur Chini Mills Limited, and Keventer Group. Throughout his professional journey, he has led numerous strategic projects, governance initiatives, and transformational changes across corporate secretarial, regulatory compliance, and legal functions, including board processes, mergers & acquisitions, under the Corporate Laws and the Listing Regulations of SEBI and SEC. d Disclosure of relationships between Not applicable directors (in case of appointment of a director).